FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327559639> ?p ?o ?g. }

• W4327559639 endingPage "100201" @default.
• W4327559639 startingPage "100201" @default.
• W4327559639 abstract "Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist pretreatment. It remains unclear if GnRH agonist pretreatment before programmed frozen embryo transfer further increases the risk for obstetrical complications among women with polycystic ovary syndrome.This study aimed to compare the obstetrical and neonatal complications of singleton and twin pregnancies after programmed frozen embryo transfer with or without gonadotropin-releasing hormone-a pretreatment among women with polycystic ovary syndrome.This was a secondary analysis of a single-center, randomized controlled trial comparing the live birth rate and cost-effectiveness of programmed cycle-prepared frozen embryo transfers with or without gonadotropin-releasing hormone agonist pretreatment among women with polycystic ovary syndrome. The analysis was restricted to women with polycystic ovary syndrome, aged 24 to 40 years, who delivered live neonates after frozen-thawed blastocyst transfer. The obstetrical and neonatal outcomes were compared between programmed cycles with and those without gonadotropin-releasing hormone agonist pretreatment. The adjusted odds ratios with 95% confidence intervals were calculated and adjustments were made for relevant confounders.The maternal and neonatal complications associated with 177 live single births and 38 twin births (253 newborns in total) were analyzed. There were no significant differences in the frequencies of obstetrical complications, including hypertensive disorders of pregnancy, between the gonadotropin-releasing hormone agonist pretreatment and no pretreatment group for both singleton and twin pregnancies. However, there was a significantly greater incidence of having a low birthweight neonate among singleton infants born after gonadotropin-releasing hormone agonist pretreatment when compared with no pretreatment (10.2% vs 1.3%; P=0.042), and a low birthweight among singleton infants was still more likely after adjusting for confounders (relative ratio, 3.85; 95% confidence interval, 1.13-7.11; P=.024). Other neonatal complications were all comparable between the pretreatment and no pretreatment groups for both singleton and twin pregnancies.For women with polycystic ovary syndrome, programmed frozen embryo transfer cycles with gonadotropin-releasing hormone agonist pretreatment could lead to a greater risk of having a low birthweight singleton neonate." @default.
• W4327559639 created "2023-03-17" @default.
• W4327559639 creator A5018357828 @default.
• W4327559639 creator A5044053727 @default.
• W4327559639 creator A5052498253 @default.
• W4327559639 creator A5055084492 @default.
• W4327559639 creator A5060413120 @default.
• W4327559639 creator A5062493663 @default.
• W4327559639 creator A5071590370 @default.
• W4327559639 date "2023-05-01" @default.
• W4327559639 modified "2023-10-14" @default.
• W4327559639 title "Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trial" @default.
• W4327559639 cites W2076769662 @default.
• W4327559639 cites W2133792952 @default.
• W4327559639 cites W2135944926 @default.
• W4327559639 cites W2165754964 @default.
• W4327559639 cites W2505179618 @default.
• W4327559639 cites W2586589965 @default.
• W4327559639 cites W2604247729 @default.
• W4327559639 cites W2612427761 @default.
• W4327559639 cites W2616235706 @default.
• W4327559639 cites W2923104520 @default.
• W4327559639 cites W2929025230 @default.
• W4327559639 cites W2959031195 @default.
• W4327559639 cites W3048586051 @default.
• W4327559639 cites W3081726549 @default.
• W4327559639 cites W3127332448 @default.
• W4327559639 cites W3212285338 @default.
• W4327559639 cites W4200340905 @default.
• W4327559639 cites W4200370600 @default.
• W4327559639 cites W4221123888 @default.
• W4327559639 cites W4256605237 @default.
• W4327559639 cites W4291885875 @default.
• W4327559639 cites W4295805920 @default.
• W4327559639 cites W4296784522 @default.
• W4327559639 doi "https://doi.org/10.1016/j.xagr.2023.100201" @default.
• W4327559639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37168544" @default.
• W4327559639 hasPublicationYear "2023" @default.
• W4327559639 type Work @default.
• W4327559639 citedByCount "0" @default.
• W4327559639 crossrefType "journal-article" @default.
• W4327559639 hasAuthorship W4327559639A5018357828 @default.
• W4327559639 hasAuthorship W4327559639A5044053727 @default.
• W4327559639 hasAuthorship W4327559639A5052498253 @default.
• W4327559639 hasAuthorship W4327559639A5055084492 @default.
• W4327559639 hasAuthorship W4327559639A5060413120 @default.
• W4327559639 hasAuthorship W4327559639A5062493663 @default.
• W4327559639 hasAuthorship W4327559639A5071590370 @default.
• W4327559639 hasBestOaLocation W43275596391 @default.
• W4327559639 hasConcept C131872663 @default.
• W4327559639 hasConcept C134018914 @default.
• W4327559639 hasConcept C160099875 @default.
• W4327559639 hasConcept C2776363309 @default.
• W4327559639 hasConcept C2777391703 @default.
• W4327559639 hasConcept C2778279030 @default.
• W4327559639 hasConcept C2778575703 @default.
• W4327559639 hasConcept C2778894405 @default.
• W4327559639 hasConcept C2779234561 @default.
• W4327559639 hasConcept C2779306644 @default.
• W4327559639 hasConcept C2781065240 @default.
• W4327559639 hasConcept C29456083 @default.
• W4327559639 hasConcept C3018442814 @default.
• W4327559639 hasConcept C512716672 @default.
• W4327559639 hasConcept C54355233 @default.
• W4327559639 hasConcept C71315377 @default.
• W4327559639 hasConcept C71924100 @default.
• W4327559639 hasConcept C86803240 @default.
• W4327559639 hasConceptScore W4327559639C131872663 @default.
• W4327559639 hasConceptScore W4327559639C134018914 @default.
• W4327559639 hasConceptScore W4327559639C160099875 @default.
• W4327559639 hasConceptScore W4327559639C2776363309 @default.
• W4327559639 hasConceptScore W4327559639C2777391703 @default.
• W4327559639 hasConceptScore W4327559639C2778279030 @default.
• W4327559639 hasConceptScore W4327559639C2778575703 @default.
• W4327559639 hasConceptScore W4327559639C2778894405 @default.
• W4327559639 hasConceptScore W4327559639C2779234561 @default.
• W4327559639 hasConceptScore W4327559639C2779306644 @default.
• W4327559639 hasConceptScore W4327559639C2781065240 @default.
• W4327559639 hasConceptScore W4327559639C29456083 @default.
• W4327559639 hasConceptScore W4327559639C3018442814 @default.
• W4327559639 hasConceptScore W4327559639C512716672 @default.
• W4327559639 hasConceptScore W4327559639C54355233 @default.
• W4327559639 hasConceptScore W4327559639C71315377 @default.
• W4327559639 hasConceptScore W4327559639C71924100 @default.
• W4327559639 hasConceptScore W4327559639C86803240 @default.
• W4327559639 hasFunder F4320321001 @default.
• W4327559639 hasIssue "2" @default.
• W4327559639 hasLocation W43275596391 @default.
• W4327559639 hasLocation W43275596392 @default.
• W4327559639 hasLocation W43275596393 @default.
• W4327559639 hasOpenAccess W4327559639 @default.
• W4327559639 hasPrimaryLocation W43275596391 @default.
• W4327559639 hasRelatedWork W1969771329 @default.
• W4327559639 hasRelatedWork W2010844854 @default.
• W4327559639 hasRelatedWork W2031635887 @default.
• W4327559639 hasRelatedWork W2091297961 @default.
• W4327559639 hasRelatedWork W2505179618 @default.
• W4327559639 hasRelatedWork W2515747482 @default.

• next